Biocon settles US patent dispute with Roche's Genentech, eyes 2027 Perjeta biosimilar launch The Times of India 02:53 Thu, 15 Oct
Gilead spends $1.28bn on PepStar’s potential Icotyde rival Pharmaceutical Technology 2h Gilead Sciences Biotech
Bottom of the Hill sold to biotech executive, will stay open as S.F. music venue San Francisco Chronicle 12h Biotech Biotechnology
Amgen vs. Eli Lilly: Does the GLP-1 mania make LLY stock a better buy in 2026? The Motley Fool 15h Eli Lilly Amgen Biotechnology
Gilead to pay $45 million to settle kickback charges filed by Texas attorney general STAT 5h Gilead Sciences Pharma
Unicycive Therapeutics announces FDA acceptance of oxylanthanum carbonate NDA resubmission and PDUFA date of march 25, 2027 JCN Newswire 1d Biotechnology
Genentech and Biocon settle pertuzumab biosimilar bpcia litigation JD Supra 2d Biocon Pharma Biotech All sources
FDA approves atezolizumab combination for stage III colon cancer with deficient DNA mismatch repair News-Medical.Net 19:20 Fri, 09 Oct Roche Pharma Biotech
SOUTH SAN FRANCISCO's Alector lands $100M Genentech deal for brain drug Hoodline 21:53 Tue, 06 Oct Alector Biotechnology Pharma
